MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Neuropsychological changes over the first 6 years of Parkinson’s disease in the ICICLE-PD cohort

    R. Lawson, G. Duncan, T. Khoo, D. Breen, M. Camacho, C. Williams-Gray, R. Barker, L. Rochester, D. Burn, A. Yarnall (Newcastle Upon Tyne, United Kingdom)

    Objective: To determine the longitudinal differences in cognitive tests in participants with Parkinson’s disease (PD), and the neuropsychological tests most sensitive to change over and…
  • 2019 International Congress

    Using Brain Atrophy and Visual Dysfunction to Predict Dementia in Parkinson’s Disease

    L-A. Leyland, R. Mahmood, R. Weil (London, United Kingdom)

    Objective: To identify areas of regional volume loss in structural brain images relating to poorer visual function and risk of dementia in Parkinson’s Disease (PD).…
  • 2019 International Congress

    Visual dysfunction and retinal thinning predict dementia risk in Parkinson’s disease

    L-A. Leyland, F. Bremner, R. Mahmood, S. Hewitt, M. Durteste, M. Cartlidge, M. Lai, L. Miller, A. Saygin, P. Keane, A. Schrag, R. Weil (London, United Kingdom)

    Objective: We assessed the role of visual measures and retinal volume (in dopaminergic layers: ganglion cell layer (GCL) and inner plexiform layer (IPL)) to predict…
  • 2019 International Congress

    Computerized cognitive test profile of 100 patients with and without Amyloid beta 1-42 burden

    F. Waga, I. Liepelt-Scarfone, M. Bentele, W. Maetzler, S. Becker, M. Timmers, L. van Nueten, G. Salvadore, K. Brockmann, M. Hobert, J. Streffer, D. Berg (Titusville, NJ, USA)

    Objective: To investigate whether a computerized neuropsychological assessment can detect subtle cognitive impairment associated with Aβ pathology in Parkinson’s disease (PD). Background: Parenchymal Aβ pathology…
  • 2019 International Congress

    Tau pathology is associated to cognitive and not motor function in Parkinson’s disease

    I. Liepelt-Scarfone, H. Vanderstichele, W. Maetzler, C. Francois, C. Schulte, M. Timmers, L. van Nueten, G. Salvadore, K. Brockmann, T. Gasser, J. Streffer, E. Stoops, D. Berg (Tübingen, Germany)

    Objective: To define the association of different cerebrospinal fluid (CSF) biomarkers reflecting Aß and Tau pathology or synaptic function with motor and/or cognitive function in…
  • 2019 International Congress

    Vascular risk factors, WMLs and the risk of cognitive impairment in Parkinson disease: A longitudinal study from the Parkinson’s Disease Cognitive Impairment Study (PaCoS) cohort

    A. Luca, R. Monastero, G. Donzuso, R. Baschi, C. Cicero, C. Terravecchia, A. Salerno, M. Zuccarello, M. Davì, V. Restivo, G. Mostile, M. Zappia, A. Nicoletti (Catania, Italy)

    Objective: To identify modifiable vascular risk factors (VRFs) associated with cognitive decline in early PD. Background: The importance of the early identification of modifiable risk…
  • 2019 International Congress

    Negative and Positive Feedback Processing in Parkinson’s Disease and Impulse Control Disorder: an ERP Study

    A. Martini, R. Schifano, L. Weis, R. Biundo, S. Tamburin, J. Brooks, A. Antonini, G. Leoni, N. Edelstyn (Newcastle-Under-Lyme, United Kingdom)

    Objective: To investigate neural correlates of positive and negative feedback processing during reward-related decision-making using the Balloon Analogue Risk task (BART) and event-related potentials (ERPs).…
  • 2019 International Congress

    Impact of Cognitive Profile on Impulse Control Disorders Presence and Severity in Parkinson’s Disease

    A. Martini, L. Weis, E. Fiorenzato, R. Schifano, V. Cianci, A. Antonini, R. Biundo (Newcastle-­under­-Lyme, United Kingdom)

    Objective: To investigate whether Parkinson’s disease (PD) cognitive states and phenotypes are associated with changes in prevalence and severity of Impulse control disorder (ICD). Background:…
  • 2019 International Congress

    Impaired colour discrimination is associated with hallucinations in Dementia with Lewy Bodies

    E. Matar, K. Ehgoetz Martens, J. Phillips, G. Halliday, S. Lewis (Sydney, Australia)

    Objective: To explore the hypothesis that color discrimination impairment seen in Lewy body disorders is a specific biomarker of visual hallucinations rather than just overall…
  • 2019 International Congress

    Differential temporal processing across Lewy body disorders and relation to cognitive fluctuations

    E. Matar, J. Phillips, K. Ehgoetz Martens, G. Halliday, S. Lewis (Sydney, Australia)

    Objective: To characterize differences in interval timing between patients with Parkinson’s disease and Dementia with Lewy bodies (DLB) and evaluate their relationship to cognitive fluctuations…
  • « Previous Page
  • 1
  • …
  • 1142
  • 1143
  • 1144
  • 1145
  • 1146
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley